Literature DB >> 9335174

Factors determining more efficient large-scale release of a periplasmic enzyme from E. coli using lysozyme.

J J Pierce1, C Turner, E Keshavarz-Moore, P Dunnill.   

Abstract

Large scale use of lysozyme for periplasmic release has been impeded by the cost of the pure enzyme and its subsequent presence as a contaminant in later downstream processing steps. In this paper, we discuss the use of lysozyme for pilot scale recovery of a periplasmic enzyme from E. coli. The effects of concentration of sucrose, lysozyme and cells on periplasmic enzyme release were examined. Lysozyme concentration can be reduced 5-fold from previous reports and a reduction in sucrose concentration from 20 to 15% (w/v) allows an improvement in centrifugal harvesting by reducing viscosity. High levels of release were still achieved using this technique and further improvements in yield were obtained by optimising other components of the releasing mixture. Results show that some release is still achieved in circumstances where no lysozyme use is possible. Results also indicate that a substantial proportion (up to 70%) of lysozyme remains bound to the cellular debris after its action and is removed with this material.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9335174     DOI: 10.1016/s0168-1656(97)00116-8

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  7 in total

1.  Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli.

Authors:  H Sletta; A Nedal; T E V Aune; H Hellebust; S Hakvåg; R Aune; T E Ellingsen; S Valla; T Brautaset
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

2.  Biogenesis of Salmonella enterica serovar typhimurium membrane vesicles provoked by induction of PagC.

Authors:  Ryo Kitagawa; Akiko Takaya; Mai Ohya; Yoshimitsu Mizunoe; Akemi Takade; Shin-ichi Yoshida; Emiko Isogai; Tomoko Yamamoto
Journal:  J Bacteriol       Date:  2010-08-27       Impact factor: 3.490

3.  Enhancing the selective extracellular location of a recombinant E. coli domain antibody by management of fermentation conditions.

Authors:  Ioannis Voulgaris; Gary Finka; Mark Uden; Mike Hoare
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-17       Impact factor: 4.813

4.  Escherichia coli "TatExpress" strains super-secrete human growth hormone into the bacterial periplasm by the Tat pathway.

Authors:  Douglas F Browning; Kirsty L Richards; Amber R Peswani; Jo Roobol; Stephen J W Busby; Colin Robinson
Journal:  Biotechnol Bioeng       Date:  2017-10-06       Impact factor: 4.530

5.  Comparative proteome analysis in an Escherichia coli CyDisCo strain identifies stress responses related to protein production, oxidative stress and accumulation of misfolded protein.

Authors:  Isabel Guerrero Montero; Katarzyna Magdalena Dolata; Rabea Schlüter; Gilles Malherbe; Susanne Sievers; Daniela Zühlke; Thomas Sura; Emma Dave; Katharina Riedel; Colin Robinson
Journal:  Microb Cell Fact       Date:  2019-01-29       Impact factor: 5.328

6.  Selective Release of Recombinant Periplasmic Protein From E. coli Using Continuous Pulsed Electric Field Treatment.

Authors:  Felix Schottroff; Jens Kastenhofer; Oliver Spadiut; Henry Jaeger; David J Wurm
Journal:  Front Bioeng Biotechnol       Date:  2021-02-09

7.  Fungal GH25 muramidases: New family members with applications in animal nutrition and a crystal structure at 0.78Å resolution.

Authors:  Olga V Moroz; Elena Blagova; Edward Taylor; Johan P Turkenburg; Lars K Skov; Garry P Gippert; Kirk M Schnorr; Li Ming; Liu Ye; Mikkel Klausen; Marianne T Cohn; Esben G W Schmidt; Søren Nymand-Grarup; Gideon J Davies; Keith S Wilson
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.